MINI FUTURE LONG - NOVARTIS N Share Price

Certificat

UZAABP

CH1332887970

Market Closed - Swiss Exchange 08:50:00 19/06/2024 pm IST
0.62 CHF +6.90% Intraday chart for MINI FUTURE LONG - NOVARTIS N
Current month+8.77%
1 month+3.33%
Date Price Change
19/24/19 0.62 +6.90%
18/24/18 0.58 -4.92%
17/24/17 0.61 -8.96%
14/24/14 0.67 +4.69%
13/24/13 0.64 -1.54%

Delayed Quote Swiss Exchange

Last update June 19, 2024 at 08:50 pm IST

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying NOVARTIS AG
IssuerLogo Issuer BNP Paribas BNP Paribas
UZAABP
ISINCH1332887970
Date issued 04/03/2024
Strike 81.77 CHF
Maturity Unlimited
Parity 20 : 1
Emission price- CHF
Emission volume N/A
Settlement cash
Currency CHF

Technical Indicators

Highest since issue 0.68 CHF
Lowest since issue 0.22 CHF
Spread 0.01 CHF
Spread %1.59%

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
106.2 USD
Average target price
110.3 USD
Spread / Average Target
+3.85%
Consensus
  1. Stock Market
  2. Certificates
  3. UZAABP Certificat